Michael Fink

1.8k total citations
74 papers, 1.1k citations indexed

About

Michael Fink is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Michael Fink has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Surgery, 35 papers in Hepatology and 21 papers in Epidemiology. Recurrent topics in Michael Fink's work include Liver Disease and Transplantation (24 papers), Organ Transplantation Techniques and Outcomes (24 papers) and Liver Disease Diagnosis and Treatment (14 papers). Michael Fink is often cited by papers focused on Liver Disease and Transplantation (24 papers), Organ Transplantation Techniques and Outcomes (24 papers) and Liver Disease Diagnosis and Treatment (14 papers). Michael Fink collaborates with scholars based in Australia, New Zealand and United States. Michael Fink's co-authors include Vijayaragavan Muralidharan, Christopher Christophi, Robert Jones, Mehrdad Nikfarjam, Graham Starkey, Kate Leslie, Paul S. Myles, David Story, S. Poustie and Paul Gow and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Michael Fink

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Fink Australia 20 596 357 293 292 213 74 1.1k
Fabio Tuzzolino Italy 19 593 1.0× 599 1.7× 527 1.8× 245 0.8× 113 0.5× 74 1.2k
Ahmed Eid Israel 24 907 1.5× 225 0.6× 179 0.6× 352 1.2× 182 0.9× 97 1.6k
Prosanto Chaudhury Canada 22 580 1.0× 482 1.4× 389 1.3× 165 0.6× 56 0.3× 85 1.4k
T.G. Walker United States 9 297 0.5× 204 0.6× 183 0.6× 373 1.3× 115 0.5× 34 1.0k
Emmanuel Melloul Switzerland 20 1.1k 1.9× 518 1.5× 260 0.9× 284 1.0× 414 1.9× 52 1.6k
Nicola Guglielmo Italy 15 423 0.7× 213 0.6× 180 0.6× 186 0.6× 74 0.3× 70 828
D Lindsell United Kingdom 19 404 0.7× 172 0.5× 243 0.8× 542 1.9× 206 1.0× 43 1.5k
Lucio Urbani Italy 19 687 1.2× 545 1.5× 198 0.7× 119 0.4× 117 0.5× 74 1.1k
Spiridon Vernadakis Germany 16 480 0.8× 196 0.5× 186 0.6× 187 0.6× 40 0.2× 54 817
Frank Lukens United States 20 798 1.3× 217 0.6× 317 1.1× 427 1.5× 59 0.3× 99 1.3k

Countries citing papers authored by Michael Fink

Since Specialization
Citations

This map shows the geographic impact of Michael Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fink more than expected).

Fields of papers citing papers by Michael Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fink. The network helps show where Michael Fink may publish in the future.

Co-authorship network of co-authors of Michael Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fink. A scholar is included among the top collaborators of Michael Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fink. Michael Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fink, Michael, et al.. (2025). Dextrans as anticoagulants and antiplatelet agents: protocol for a scoping review. BMJ Open. 15(6). e092284–e092284.
2.
Maeda, Akinori, Graham Starkey, Glenn M. Eastwood, et al.. (2024). Perfusate hemoglobin during normothermic liver machine perfusion as biomarker of early allograft dysfunction: A pilot study. Artificial Organs. 49(1). 108–118.
3.
Fink, Michael, Paul Gow, Geoffrey W. McCaughan, et al.. (2023). Impact of Share 35 liver transplantation allocation in Australia and New Zealand. Clinical Transplantation. 38(1). e15203–e15203.
4.
5.
Lee, Eunice, Michael Fink, Graham Starkey, et al.. (2023). A Single Centre Experience with Pre-Operative Markers in the Prediction of Outcomes after Liver Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery. 27(7). 1376–1386. 2 indexed citations
6.
Barreto, Savio George, Simone I. Strasser, Geoffrey W. McCaughan, et al.. (2022). Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0. Cancers. 14(11). 2777–2777. 7 indexed citations
7.
Perini, Marcos V., Laurence Weinberg, Michael Fink, et al.. (2021). Reduction in post‐operative pancreatic fistula with polyethylene glycol and recombinant human albumin sealant following stapled distal pancreatectomy. ANZ Journal of Surgery. 91(11). 2459–2465. 5 indexed citations
8.
Sinclair, Marie, Adam Testro, Peter Angus, et al.. (2019). Epidemiology and outcomes of acute liver failure in Australia. World Journal of Hepatology. 11(7). 586–595. 20 indexed citations
9.
Gow, Paul, Michael Fink, Anouk Dev, et al.. (2018). Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population‐based study. The Medical Journal of Australia. 209(8). 348–354. 43 indexed citations
10.
Fink, Michael, Marcos V. Perini, Laurence Weinberg, et al.. (2017). Age 80 years and over is not associated with increased morbidity and mortality following pancreaticoduodenectomy. ANZ Journal of Surgery. 88(5). E445–E450. 20 indexed citations
11.
Fink, Michael, Sally Bell, Paul Gow, et al.. (2015). Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study. Scandinavian Journal of Gastroenterology. 50(5). 567–576. 29 indexed citations
12.
Bellomo, Rinaldo, Satoshi Suzuki, Bruno Marino, et al.. (2012). Normothermic extracorporeal perfusion of isolated porcine liver after warm ischaemia: a preliminary report. Critical Care and Resuscitation. 14(3). 173–176. 14 indexed citations
13.
Howell, Jessica, Paul Gow, Peter Angus, et al.. (2012). Early-onset versus late-onset nonanastomotic biliary strictures post liver transplantation: risk factors reflect different pathogenesis. Transplant International. 25(7). 765–775. 28 indexed citations
14.
Nikfarjam, Mehrdad, Vijayaragavan Muralidharan, Niall C. Tebbutt, et al.. (2012). Biliary stenting versus surgical bypass for palliation of periampullary malignancy. Indian Journal of Gastroenterology. 32(2). 82–89. 3 indexed citations
15.
Hodgson, Russell, Michael Fink, & Robert M. Jones. (2007). THE ROLE OF ABDOMINAL RESECTIONAL SURGERY IN METASTATIC MELANOMA. ANZ Journal of Surgery. 77(10). 855–859. 6 indexed citations
16.
Fink, Michael, Paul Gow, Peter Angus, et al.. (2006). Risk factors for liver transplantation waiting list mortality. Journal of Gastroenterology and Hepatology. 22(1). 119–124. 42 indexed citations
17.
Fink, Michael & Robert Jones. (2005). The use of a composite graft of iliac artery and inferior mesenteric vein in liver transplantation. Transplant International. 19(1). 81–83. 1 indexed citations
18.
Fink, Michael, Peter Angus, Paul Gow, et al.. (2005). Liver Transplant Recipient Selection: MELD vs. Clinical Judgment. Liver Transplantation. 11(6). 621–626. 30 indexed citations
19.
Fink, Michael, et al.. (1987). Experimental folic acid nephropathy. Pathology. 19(2). 143–149. 40 indexed citations
20.
Ziegler, Irmgard, Michael Fink, & W. Wilmanns. (1982). Biopterin level in peripheral blood cells as a marker for hemopoietic cell proliferation during leukemia and polycythemia vera. Annals of Hematology. 44(4). 231–240. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026